ICON Public Limited Company

Equities

Real-time Estimate Cboe BZX Other stock markets 15:44:56 17/02/2026 GMT			5-day change	1st Jan Change
90.40 ^USD	-2.80%		-37.58%	-50.49%

01:12pm	Deutsche Bank Adjusts ICON Price Target to $160 From $205, Maintains Buy Rating	MT
12:53pm	Rothschild & Co Redburn Downgrades ICON to Neutral From Buy, Adjusts Price Target to $100 From $226	MT

Published on 05/01/2025 at 07:17 am BST - Modified on 07/14/2025 at 08:20 pm BST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good day, and thank you for standing by. Welcome to the ICON plc Q1 2025 Earnings Conference Call. [Operator Instructions] Please be advised, today's

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

01:12pm	Deutsche Bank Adjusts ICON Price Target to $160 From $205, Maintains Buy Rating	MT
12:53pm	Rothschild & Co Redburn Downgrades ICON to Neutral From Buy, Adjusts Price Target to $100 From $226	MT
02-12	Sector Update: Health Care Stocks Higher Thursday Afternoon	MT
02-12	Top Midday Decliners	MT
02-12	Top Midday Stories: ICON Launches Internal Probe Into Accounting Practices; AppLovin Shares Fall Despite Strong Q4 Earnings, Guidance	MT
02-12	ICON Shares Slump Amid Internal Investigation	MT
02-12	Top Premarket Decliners	MT
01-27	ICON?s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership	CI
01-08	Peace Was Cheaper
01-08	Truist Downgrades ICON PLC to Hold From Buy, Trims Price Target to $222 From $231	MT
01-08	Analyst recommendations: Alphabet, Chubb, Ford, Stellantis, The Gap…
12-15	BofA Securities Downgrades ICON to Neutral From Buy	MT
12-09	ICON plc Releases Findings from Two Biotech Sector Survey	CI
12-02	Icon survey reveals increasing clinical trial startup delays	RE
12-02	Icon plc Announces Results of Its Latest Industry Survey	CI